Suggestions
Nimish Gera
Head of Biologics at Mythic Therapeutics
Professional Background
Nimish Gera is a seasoned Scientific Leader with over 13 years of extensive experience in Protein and Antibody Discovery and Engineering. He has successfully led dynamic and high-performing cross-functional teams through the intricate processes of discovery to Investigational New Drug (IND) applications. His journey reflects a profound commitment to advancing scientific frontiers, especially in the realms of antibody and protein therapeutics. As Head of Biologics at Mythic Therapeutics, Nimish plays a pivotal role in driving innovative research and development strategies that aim to revolutionize therapeutic solutions.
Prior to his current position, he has held several prestigious roles, including Scientific Co-Founder and Director of Research and Development at Mythic Therapeutics, as well as multiple research scientist positions at Alexion Pharmaceuticals, where he was deeply involved in discovery research and molecular sciences. His rich history also includes significant contributions as a Senior Scientist in Discovery Sciences at Oncobiologics Inc. Nimish's analytical prowess encompasses a diverse range of techniques geared towards optimizing processes in biologics discovery and manufacturing, including biophysical characterization and developability assessments.
Education and Achievements
Nimish's academic foundation is solidified by a PhD in Chemical and Biomolecular Engineering, which he earned from North Carolina State University with an impressive GPA of 4.0/4.0. This educational journey has equipped him with the necessary skills and knowledge that have propelled his career in the field of biopharmaceutical sciences. His Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology, Guwahati, is a testament to his strong technical background and dedication to engineering sciences.
In addition to his academic accomplishments, Nimish has also served as an Assistant Editor at Mabs, a reputable journal published by Taylor & Francis Group, where he contributed to the dissemination of knowledge in the field of monoclonal antibodies. His scientific contributions extend beyond his job roles, serving as a platform for him to influence and mentor burgeoning scientists in the industry.
Notable Achievements
Nimish Gera's key specialties include Antibody Discovery and Protein Engineering utilizing advanced methodologies such as Phage Display, Yeast Display, and mRNA Display. He has a proven track record in developing bispecific antibodies and antibody-drug conjugates that are critical in the consolidation of therapies for complex diseases. His expertise also extends to various aspects of protein therapeutics including library design and construction, panning, biophysical characterization, affinity maturation, and more.
His mastery of analytical tools, from Fluorescence-Activated Cell Sorting (FACS) to Surface Plasmon Resonance, has rendered him an invaluable asset in both academic and industry settings. By fostering a culture of mentoring and problem-solving within his teams, Nimish not only drives project success but also emphasizes career development for scientists at different levels, bridging the gap between academic training and industry demands.
Nimish's comprehensive approach integrates various aspects of research—from conceptualization and library screening to purification and bioassay development—ensuring that the transition from lab to clinical application is both efficient and effective. His holistic view of the drug development process underlines his ability to manage complex projects and innovate best practices in science and technology.
title
Nimish Gera: Leading Expert in Protein Engineering and Antibody Discovery